Cushing's syndrome (CS) causes metabolic abnormalities that determine an increased cardiovascular risk not only during the active phase of the disease but also for a long time after cure. Cardiovascular complications, such as premature atherosclerosis, coronary artery disease, heart failure, and stroke, in patients with CS cause a mortality rate higher than that observed in a normal population. The increased cardiovascular risk is mainly due to metabolic complications, such as metabolic syndrome, but also to vascular and cardiac alterations such as atherosclerosis and cardiac structural and functional changes. In the clinical management of patients with CS the focus should be on identifying the global cardiovascular risk and the aim should be to control not only hypertension but also other correlated risk factors, such as obesity, glucose intolerance, insulin resistance, dyslipidemia, endothelial dysfunction and the prothrombotic state. Considering that remission from hypercortisolism is often difficult to achieve and that the cardiovascular risk can persist even during disease remission, care and control of all cardiovascular risk factors should be one of the primary goals during the follow-up of these patients.

Cardiovascular disease in Cushing's syndrome: heart versus vasculature / De Leo, M; Pivonello, R; Auriemma, Rs; Cozzolino, A; Vitale, P; Simeoli, C; De Martino, Mc; Lombardi, G; Colao, A. - 92:suppl.1(2010), pp. 50-54. (Intervento presentato al convegno 1st European Neuroendocrine Association (ENEA) Workshop tenutosi a Napoli) [10.1159/000318566].

Cardiovascular disease in Cushing's syndrome: heart versus vasculature

Cozzolino A;
2010

Abstract

Cushing's syndrome (CS) causes metabolic abnormalities that determine an increased cardiovascular risk not only during the active phase of the disease but also for a long time after cure. Cardiovascular complications, such as premature atherosclerosis, coronary artery disease, heart failure, and stroke, in patients with CS cause a mortality rate higher than that observed in a normal population. The increased cardiovascular risk is mainly due to metabolic complications, such as metabolic syndrome, but also to vascular and cardiac alterations such as atherosclerosis and cardiac structural and functional changes. In the clinical management of patients with CS the focus should be on identifying the global cardiovascular risk and the aim should be to control not only hypertension but also other correlated risk factors, such as obesity, glucose intolerance, insulin resistance, dyslipidemia, endothelial dysfunction and the prothrombotic state. Considering that remission from hypercortisolism is often difficult to achieve and that the cardiovascular risk can persist even during disease remission, care and control of all cardiovascular risk factors should be one of the primary goals during the follow-up of these patients.
2010
1st European Neuroendocrine Association (ENEA) Workshop
atherosclerosis; Cushing's syndrome; cardiovascular disease
04 Pubblicazione in atti di convegno::04b Atto di convegno in volume
Cardiovascular disease in Cushing's syndrome: heart versus vasculature / De Leo, M; Pivonello, R; Auriemma, Rs; Cozzolino, A; Vitale, P; Simeoli, C; De Martino, Mc; Lombardi, G; Colao, A. - 92:suppl.1(2010), pp. 50-54. (Intervento presentato al convegno 1st European Neuroendocrine Association (ENEA) Workshop tenutosi a Napoli) [10.1159/000318566].
File allegati a questo prodotto
File Dimensione Formato  
DeLeo_Cardiovascular-disease-Cushings_2010.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 160.31 kB
Formato Adobe PDF
160.31 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1203140
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 83
  • ???jsp.display-item.citation.isi??? 66
social impact